Plain-English translation of NCT06598033 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether vitamin C plus Cordyceps (a medicinal fungus) and Reishi (an herbal supplement) can help reduce side effects from chemotherapy and improve daily quality of life for people with advanced pancreatic cancer. You would be eligible if your cancer has continued to grow even after receiving two different chemotherapy treatments. The study will measure how the medication affects pain, numbness in hands and feet, fatigue, anemia, and overall survival.
Standard chemotherapy for advanced pancreatic cancer can cause serious side effects like numbness, pain, tiredness, and anemia that make daily life very difficult. This trial exists to see whether this medication might help ease those side effects and improve how patients feel when other treatment options are limited.
You likely qualify if…
You likely don't qualify if…
You would take vitamin C by mouth three times daily (900 mg total per day) along with Reishi and Cordyceps twice daily as oral supplements. The study will track how these supplements affect your quality of life, pain levels, numbness, anemia, and how long you survive. The trial involves 50 patients total, and researchers will measure your symptoms and blood work regularly to see if the treatment helps.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
China
Phase
Large-scale testing
Sponsor
Fudan University
Enrollment target
~50 participants
Started
November 2024
Primary completion
October 2026
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in November 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Huanyu Xia, MD
Shanghai Cancer Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.